河北医科大学学报

• 论著 • 上一篇    下一篇

法舒地尔联合丁苯酞软胶囊治疗急性脑梗死的效果及对血清MMP2、MMP9水平的影响

  

  1. 1.河北省人民医院神经内科,河北 石家庄 050051;2. 河北省人民医院心内科,河北 石家庄 050051
  • 出版日期:2018-12-25 发布日期:2018-11-30
  • 作者简介:尹楠(1984-),女,河北保定人,河北省人民医院主治医师,医学硕士,从事神经内科疾病诊治研究。
  • 基金资助:
    河北省医学科学研究重点课题(20170003)

Effect of fasudil hydrochloride combined with butylphthalide soft capsules on treatment of acute cerebral infarction and serum level of MMP2 and MMP9#br#

  1. .Department of Neurology,Hebei General Hospital, Shijiazhuang 050051, China;
    2.Department of Cardiology,Hebei General Hospital, Shijiazhuang 050051, China
  • Online:2018-12-25 Published:2018-11-30

摘要: [摘要]〓
〖HTH〗目的〖HTSS〗〖KG*2〗观察盐酸法舒地尔注射液联合丁苯酞软胶囊治疗急性脑梗死14 d的美国国立卫生研究院卒中量表(National Institute of Health Stroke Scale,NIHSS)评分改善及对血清基质金属蛋白酶2(matrix metalloproteinase2,MMP2)、基质金属蛋白酶9(matrix metalloproteinase9,MMP9)表达水平的影响。
〖HTH〗方法〖HTSS〗〖KG*2〗将78例急性脑梗死患者随机分为观察组和对照组各39例。对照组采用常规对症治疗,观察组在对照组治疗基础上加用盐酸法舒地尔注射液静脉滴注和丁苯酞软胶囊口服,2组均连续治疗14 d。分别于治疗前后采用NIHSS评分对2组进行神经功能测定,并对治疗前后MMP2、MMP9水平进行比较。
〖HTH〗结果〖HTSS〗〖KG*2〗经过14 d的治疗,观察组总有效率优于对照组(P<005),2组NIHSS评分及血清MMP2、MMP9水平均较治疗前显著降低(P<005),但观察组降低幅度更大,治疗后观察组NIHSS评分及血清MMP2、MMP9水平均低于对照组,差异有统计学意义(P<005)。
〖HTH〗结论〖HTSS〗〖KG*2〗盐酸法舒地尔注射液联合丁苯酞软胶囊可降低急性脑梗死患者的NIHSS评分,显著下调血清中MMP2、MMP9的表达。其机制可能与抑制炎症反应、减轻卒中后继发性脑损伤有关。

关键词: 脑梗死, 法舒地尔, 丁苯酞, 基质金属蛋白酶类

Abstract: [Abstract] Objective〖HTSS〗〓To study the improvement of National Institute of Health Stroke Scale(NIHSS)score of fasudil hydrochloride injection combined with butylphthalide soft capsules in the 14 d treatment of acute cerebral infarction and the effect on the expression levels of matrix metalloproteinase2(MMP2) and matrix metalloproteinase9(MMP9)in serum.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓Seventyeight patients with acute cerebral infarction were randomly divided into observation group and control group, 39 cases in each group. The control group was given conventional symptomatic treatment. On the basis of the control group, the observation group was iv administered with fasudil hydrochloride injection and po administered butylphthalide soft capsules. Both groups were treated for 14 consecutive days. The two groups were assessed with NIHSS for neurologic function and MMP2 and MMP9 levels before and after treatment were compared.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓After 14 days treatment, the total effective rate of the observation group were better than those of the control group, and the difference was significant between two groups(P<005).The NIHSS scores and serum levels of MMP2 and MMP9 of two groups both significantly decreased after treatment(P<005), and the indexes of the observation group decreased even more than those in the control group, the NIHSS scores and serum levels of MMP2 and MMP9 of the observation group were lower than that of the control group after treatment, presenting statistical significance(P<005).
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓Fasudil hydrochloride injection combined with butylphthalide soft capsules can decrease the NIHSS score of patients with acute cerebral infarction,significantly downregulate the expression of MMP2 and MMP9 in serum. The mechanism may be related to inhibiting the inflammatory response, thereby reducing secondary brain injury after stroke.

Key words: braininfarction, fasudil, butylphthalide, matrix metalloproteinases